Company profile
Oxular Developing novel drug/device combination treatments for sight threatening retinal diseases.
Oxular Limited is a UK company with status active founded in 2014 based in London.
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
CH01 | Transaction MzQzODYwNjY1NmFkaXF6a2N4
Published 07 Oct 2024 03:23
MR04 | Transaction MzQzNDMyMzIwMGFkaXF6a2N4
Published 03 Sep 2024 15:15
Company registered at Companies House
1 Dec 2021 to 31 Jan 2022
The aim of this project is to advance the development of a new drug product and drug delivery device for the treatment of Retinoblastoma, a childhood cancer of the eye. This type of ocular cancer affects children globally and often results in loss of vision or spreading of life-threatening cancers to other parts of the body. Visual impairment and blindnes...
1 Jul 2019 to 30 Jun 2023
"The aim of this project is to advance development of a new drug product and drug delivery device for the treatment of Retinoblastoma, a childhood cancer of the eye. This type of ocular cancer affects children globally and often result in loss of vision or spreading of life-threatening cancers to other parts of the body. Visual impairment and blindness ca...
1 Mar 2018 to 30 Apr 2019
The aim of this project is to evaluate the commercial potential of novel treatments for uveal melanoma. Uveal melanoma is the most prevalent form of ocular cancer and diagnosis rates are rising as populations age and are exposed to more UV light. Ocular cancers affect tens of thousands of lives globally and often result in loss of vision and spreading of ...
1 Jan 2017 to 31 Dec 2018
The aim of this project is to advance early stage development of a novel drug delivery device and a related drug product for the treatment of cancers in the eye. Ocular cancers affect tens of thousands of lives globally, including the very young and elderly, and often result in loss of vision or spreading of life threatening cancers to other parts of the ...
